Home › Funds › Royce & Associates › AKBA
Royce & Associates position in AKBA
AKEBIA THREAPEUTICS INC · Health Care
Latest position (Q1 2026)28.37K sh
Reported value held$39.44K
Portfolio Weight0.00%
First reportedQ1 2026
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 28.37K | $39.44K | New |
Other funds holding AKBA
- Vanguard Group 16.02M sh · $25.79M · Q4 2025
- BlackRock Inc 19.99M sh · $22.78M · Q2 2026
- AQR Capital Management 9.15M sh · $10.43M · Q2 2026
- Geode Capital Management 6.73M sh · $7.67M · Q2 2026
- Goldman Sachs Group 3.69M sh · $4.21M · Q2 2026
- Millennium Management 3.20M sh · $3.64M · Q2 2026
- Two Sigma Investments 2.44M sh · $2.78M · Q2 2026
- Charles Schwab Investment Management 2.30M sh · $2.62M · Q2 2026
- Northern Trust Corp 2.16M sh · $2.46M · Q2 2026
- Fidelity Management & Research (FMR) 1.87M sh · $2.13M · Q2 2026
- UBS Group AG 1.37M sh · $1.57M · Q2 2026
- Renaissance Technologies 1.22M sh · $1.40M · Q2 2026